Evidence map›Paper›PMID 38782466›Full record

Trial reportThe European respiratory journal2024

Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based, non-randomised clinical trial from Kandahar, Afghanistan.

Anita Mesic, Ine Decuyper, Sadiqqullah Ishaq, Taiba Azizi, Fazal Hadi Ziamal, Shirbaz Amiri, Kees Keus, Moe Thandar Pyae, Khan Mohammed Mangal, Hashim Khan Amirzada and 4 more

Abstract readLetterClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The European respiratory journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anita MesicMédecins Sans Frontières, Public Health Department, Amsterdam, The Netherlands anitamesic@gmail.com.
Ine DecuyperInstitute of Tropical Medicine, Department of Clinical Sciences, Antwerp, Belgium.ORCID https://orcid.org/0000-0001-8127-5791
Sadiqqullah IshaqMédecins Sans Frontières, Kandahar, Islamic Republic of Afghanistan.
Taiba AziziMédecins Sans Frontières, Kandahar, Islamic Republic of Afghanistan.
Fazal Hadi ZiamalMédecins Sans Frontières, Kabul, Islamic Republic of Afghanistan.
Shirbaz AmiriMédecins Sans Frontières, Kandahar, Islamic Republic of Afghanistan.
Kees KeusMédecins Sans Frontières, Public Health Department, Amsterdam, The Netherlands.
Moe Thandar PyaeMédecins Sans Frontières, Kandahar, Islamic Republic of Afghanistan.
Khan Mohammed MangalMinistry of Public Health, National Tuberculosis Program, Kabul, Islamic Republic of Afghanistan.
Hashim Khan AmirzadaMinistry of Public Health, National Tuberculosis Program, Kabul, Islamic Republic of Afghanistan.
Assadullah RasooliMinistry of Public Health, National Tuberculosis Program, Kabul, Islamic Republic of Afghanistan.
Mohammad Reza AloudalWorld Health Organization, Kabul, Islamic Republic of Afghanistan.
Mohammad Zaher DaldarMinistry of Public Health, National Tuberculosis Program, Kabul, Islamic Republic of Afghanistan.
Tom DecrooInstitute of Tropical Medicine, Department of Clinical Sciences, Antwerp, Belgium.ORCID https://orcid.org/0000-0002-1205-1484

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antitubercular AgentsRifampinTuberculosis, Multidrug-ResistantAdministration, OralAfghanistanChildChild, PreschoolFemaleHumansInfantMaleMycobacterium tuberculosisTreatment OutcomeAntitubercular AgentsRifampin

Identifiers

PMID38782466
PMCPMC11137330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.